An Integrated Genomic Analysis of Human Glioblastoma Multiforme

By D. W. Parsons, Siân Jones, Xiaosong Zhang, Jimmy Lin, R. Leary, P. Angenendt, P. Mankoo, Hannah Carter, I. Siu, G. Gallia and 23 more. Science, 2008

5,476 citations recorded by the source corpus.

Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer. To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, determined the presence of amplifications and deletions using high-density oligonucleotide arrays, and performed gene expression analyses using next-generation sequencing technologies in 22 human tumor samples. This comprehensive analysis led to the discovery of a variety of genes that were not known to be altered in GBMs. Most notably, we found recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) in 12% of GBM patients. Mutations in IDH1 occurred in a large fraction of young patients and in most patients with secondary GBMs and were associated with an increase in overall survival. These studies demonstrate the value of unbiased genomic analyses in the characterization of human brain cancer and identify a potentially useful genetic alteration for the classification and targeted therapy of GBMs.

Subfields: Cancer Research, Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/0b3356f85f7bfefa9dd7b241b002ec71e343ca2f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Genetics

In Molecular Biology

Citations in the corpus

Tumor heterogeneity: causes and consequences (2009, background): “Intensive studies in the field of cancer genetics, and recent sequencing of cancer genomes [49–51] allowed the identification of cancer-type-specific subsets of genes that “drive” cancer progression.”
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences (2011, neutral): “Cancer-related changes include specific mutations in gene sequence”
MODBASE: a database of annotated comparative protein structure models and associated resources (2005, background): “org/LSMut, (31,32)] are collections of annotated DNA sequence variants in protein-coding exons that result in an amino acid residue-type substitution.”
Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. (2012, positive): “In particular, the pyruvate kinase M2 isoform PKM2, isocitrate dehydrogenase IDH1/2, and phosphoglycerate dehydrogenase PHGDH have been implicated in multiple cancers (Christofk et al., 2008; Parsons et al., 2008; Dang et al., 2009; Locasale et al., 2011; Possemato et al., 2011).”
The integrated landscape of driver genomic alterations in glioblastoma (2013, background): “4 and 5 ) and is expressed in normal brain ( Supplementary Table 9 ).”
Structure-based Systems Biology for Analyzing Off-target Binding (2011, background): “From a causal perspective, multiple node failures have been called “fail-on” [3], and used to explain neurological disorders [5] and cancer [6,7] in recent genome-wide studies.”
Epigenetic Determinants of Cancer. (2016, background): “These tumors arise in glial cell progenitors (Parsons et al. 2008; Noushmehr et al. 2010).”
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. (2011, background): “[26] Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P,”
Accumulation of driver and passenger mutations during tumor progression (2009, background): “(8) sequenced 20,661 protein coding genes in a series of GBM tumors and found a total of 713 somatic mutations in the 14 samples that are depicted in Fig.”